[Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic][COVID-19 범유행 기간 동안 아비라테론 아세테이트와 함께 코르티코스테론 요법의 위험에 대한 업데이트]Review Published on 2021-04-012022-08-31 Journal: Progrès en urologie : journal de l'Association fra [Category] MERS, meta-analysis, SARS, 임상, [키워드] abiraterone Abiraterone acetate Abstract Acetate Acétate d’abiratérone Combination Corticothérapie Corticotherapy COVID-19 COVID-19 pandemic Pandémie COVID-19. risk therapy [DOI] 10.1016/j.purol.2020.12.002 PMC 바로가기 [Article Type] Review
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening systemArticle Published on 2020-05-282023-06-16 Journal: Pharmacological research [Category] MERS, SARS, [키워드] abiraterone Abiraterone acetate (PubChem CID: 9821849) Antiviral Bexarotene Bexarotene (PubChem CID: 82146) Cetilistat Cetilistat (PubChem CID: 9952916) coronavirus COVID-19 Diiodohydroxyquinoline Diiodohydroxyquinoline (PubChem CID: 3728) library SARS-CoV-2 Treatment [DOI] 10.1016/j.phrs.2020.104960 PMC 바로가기 [Article Type] Article